Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Elevation Oncology, Inc. ELEV
$3.77
-$0.09 (-2.33%)
На 18:04, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
93718548.00000000
-
week52high
4.61
-
week52low
0.72
-
Revenue
0
-
P/E TTM
-1
-
Beta
0.00000000
-
EPS
-5.09000000
-
Last Dividend
0.00000000
-
Next Earnings Date
04 мая 2023 г. в 04:00
Описание компании
Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-1 fusion. Elevation Oncology, Inc. was incorporated in 2019 and is based in New York, New York.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| JP Morgan | Neutral | Overweight | 08 авг 2022 г. |
| Wedbush | Outperform | Outperform | 04 мар 2022 г. |
| HC Wainwright & Co. | Buy | 23 дек 2021 г. | |
| Wedbush | Outperform | 20 июл 2021 г. | |
| SVB Leerink | Outperform | 20 июл 2021 г. | |
| JP Morgan | Underweight | Neutral | 10 ноя 2022 г. |
| SVB Leerink | Market Perform | Outperform | 07 ноя 2022 г. |
| SVB Leerink | Market Perform | Market Perform | 09 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Jansen Valerie Malyvanh | A | 130000 | 130000 | 06 янв 2023 г. |
| Ferra Joseph J Jr | A | 30000 | 30000 | 06 янв 2023 г. |
| Ferra Joseph J Jr | A | 240000 | 240000 | 06 янв 2023 г. |
| Dornan David | A | 130000 | 130000 | 06 янв 2023 г. |
| Ferra Joseph J Jr | D | 125622 | 12562 | 16 дек 2022 г. |
| Ferra Joseph J Jr | D | 46732 | 4773 | 16 дек 2022 г. |
| Ferra Joseph J Jr | A | 51505 | 12562 | 16 дек 2022 г. |
| Ferra Joseph J Jr | D | 138184 | 12562 | 16 сент 2022 г. |
| Ferra Joseph J Jr | D | 38943 | 4773 | 16 сент 2022 г. |
| Ferra Joseph J Jr | A | 43716 | 12562 | 16 сент 2022 г. |
Новостная лента
How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
MarketBeat
26 янв 2023 г. в 04:03
The 2023 calendar year has already been rocky for many biotech companies. Just three weeks into the new year, layoffs are already plaguing the industry.
Elevation Oncology to Present Initial Seribantumab Proof-of-Concept Data from Phase 2 CRESTONE Study in Patients with Tumors Harboring NRG1 Fusions at ASCO 2022
PRNewsWire
26 мая 2022 г. в 17:05
Positive initial data support the potential of seribantumab to induce deep and durable benefit for patients with tumors harboring NRG1 fusions Clinical activity observed includes a 33% response rate with 2 complete responses across all tumor types harboring NRG1 fusions, and a 36% response rate in patients with NSCLC; ongoing durations of response range from 1.4 – 11.5 months Seribantumab has been well-tolerated in patients with tumors harboring NRG1 fusions Company to host an investor conference call to discuss these initial results from the CRESTONE study today at 6:00pm ET NEW YORK , May 26, 2022 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), a clinical stage biopharmaceutical company focused on the development of precision medicines for patients with genomically defined cancers, today announced positive initial clinical proof-of-concept data from its ongoing Phase 2 CRESTONE study evaluating the safety and efficacy of seribantumab in patients with advanced solid tumors that harbor NRG1 gene fusions. These data will be presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, being held in Chicago from June 3-7, 2022.
Best Penny Stocks to Buy as May Ends? 3 to Watch Right Now
PennyStocks
25 мая 2022 г. в 16:51
Check these penny stocks out for your watchlist The post Best Penny Stocks to Buy as May Ends? 3 to Watch Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Why Elevation Oncology Stock Is Rising
Benzinga
25 мая 2022 г. в 10:22
Elevation Oncology Inc (NASDAQ: ELEV) shares are trading higher Wednesday after the company announced the U.S. Food and Drug Administration granted Fast Track designation to seribantumab for the tumor-agnostic treatment of advanced solid tumors that harbor NRG1 gene fusions. Seribantumab.